PATRICK BUNYI: Open Payments
NPI 1871518787 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 26 payments from 11 companies in 2025. Trend: 2023 $982 · 2024 $1,205 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| ABBVIE INC. | 2 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Indivior Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, AIRSUPRA, JOURNAVX, FUROSCIX, PREVNAR 20, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
